THE oral contraceptive pill (OCP, or 'the Pill') could help reduce the risk of ovarian cancer by reducing the number of ovulations, according to new research from the University of South Australia (UniSA).
Using AI to screen for risk factors of ovarian cancer, the researchers found that the oral contraceptive pill reduced the risk of ovarian cancer by 26% among women who had ever used the Pill, and by 43% for women who had used it after the age of 45, while women with two or more children also had reduced risk.
"This poses the question as to whether interventions that reduce the number of ovulations could be used as a potential target for prevention strategies for ovarian cancer," said UniSA researcher Dr Amanda Lumsden.
The above article was sent to subscribers in Pharmacy Daily's issue from 03 Feb 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Feb 25
